A.D.
A.D., licence 80031460: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Chenchiam Inc. (Sunrider International Canada)
- NPN or DIN-HM
- 80031460
- Status
- Active licence
- Licence date
- 16 April 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Atractylodes chinensis Source : Rhizome | 56.25 mg | Not calculated |
| Panax ginseng Source : Racine | 56.25 mg | Not calculated |
| Wolfiporia extensa Source : Corps fructifère Extraction ratio : 3:1 Dry plant equivalent : 52.5 mg | 17.5 mg | Not calculated |
| Pinellia ternata Source : Rhizome (prepared) Extraction ratio : 3:1 Dry plant equivalent : 37.5 mg | 12.5 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce Source : Graine(s) | 30.0 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine et stolon | 37.5 mg | Not calculated |
| Mentha canadensis Source : Parties aériennes | 37.5 mg | Not calculated |
| Citrus reticulata Source : Pelure Extraction ratio : 3:1 Dry plant equivalent : 37.5 mg | 12.5 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine et stolon Extraction ratio : 3:1 Dry plant equivalent : 37.5 mg | 12.5 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 3.0 Tous les jours |
| Adultes | Not specified | 3.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
At 2 capsule 3 times daily: Supportive therapy for the promotion of healthy glucose levels. Helps support cognitive function and/or reduce mental fatigue (in cases of mental stress). Used in Herbal Medicine to help enhance physical capacity/performance (in cases of physical stress) At 3 capsules 3 times daily: Licorice is traditionally used in Herbal Medicine as an expectorant to help relieve chest complaints, such as catarrhs, coughs and bronchitis. Used in Herbal Medicine to help relieve inflammatory conditions of the gastrointestinal tract, such as gastritis in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80031460
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.